Key facts
- It has raised $160K; the latest was Early Stage VC in Feb 2025.
- Notable investors include Antler, MedTech Innovator, XRC Ventures, Gandel Invest, Melbourne Accelerator Program.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Sapyen
- ·The full record, as it builds
Funding rounds
No funding rounds for Sapyen are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sapyen
Developer of a reproductive health diagnostic platform intended to make fertility tests affordable and efficient. The company's platform offers fertility test kits, online sessions with customer experts, and personalized recommendations, allowing men to get their fertility checked in the convenience of their homes.
- Sector
- Healthcare
- HQ
- Carlton, Australia
- Founded
- 2021
- Employees
- 12
- Website
- sapyen.co/
- Ownership
- Privately Held (backing)
Sapyen doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sapyen shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sapyen in its N-PORT filings yet. We sweep new filings monthly.